Statement
9 Sep 2024
Eleventh meeting of the Intergovernmental Negotiating Body (INB)
On 9 September 2024, IFPMA delivered a statement at the eleventh meeting of the Intergovernmental Negotiating Body (INB) in Geneva, Switzerland. Thank you for this opportunity to continue being engaged in the INB process. The biopharmaceutical industry is committed to achieving a Pandemic Agreement that works. We believe it is possible to reach an agreement...
Read more
Statement
29 Aug 2024
AMATA statement on the Framework for strengthening local production of medicines, vaccines, and other health technologies in the WHO African Region 2025-2035
On 29 August at the 74th WHO Africa Regional Committee Meeting in Brazzaville, Republic of Congo, the African Medicines Agency Treaty Alliance delivered a statement on Agenda item 10: Framework for strengthening local production of medicines, vaccines, and other health technologies in the WHO African Region 2025-2035.
Read more
Statement
28 Aug 2024
IFPMA statement on the Framework for strengthening local production of medicines, vaccines, and other health techonologies in the WHO African Region 2025-2035
On 28 August at the 74th WHO Africa Regional Committee Meeting in Brazzaville, Republic of Congo, IFPMA submitted a statement on Agenda item 10: Framework for strengthening local production of medicines, vaccines, and other health technologies in the WHO African Region 2025-2035.
Read more